Synthesis of galectin inhibitors using organometallic chemistry

CARB 53

Nuria Parera Pera, nuriapar@chembio.chalmers.se1, Anders Bergh1, Henrik Gradén1, Hakon Leffler, hakon.leffler@med.lu.se2, Thomas Olsson3, Ulf Nilsson4, and Nina Kann, kann@chalmers.se1. (1) Department of Chemical and Biological Engineering / Organic Chemistry, Chalmers University of Technology, Kemivägen 10, Gothenburg, SE-412 96, Sweden, (2) Department of Laboratory Medicine, Sect. MIG (Microbiology, Immunology, Glycobiology), Lund University, Lund, 22362, Sweden, (3) Medicinal Chemistry, AstraZeneca R & D Mölndal, Pepperedsleden 1, 43183 Mölndal, Sweden, (4) Organic and Bioorganic Chemistry, Lund University, Lund, PO Box 124, SE-221 00, Sweden

The galectins are a family of proteins which contain shared sequence elements and show an affinity for galactosidases. One example is galectin-3 which has been implicated in many biological phenomena such as proinflammatory response, immunity, cancer, and injury of nerve cells. There is also evidence suggesting that an induced expression of galectin-3 promotes tumor growth and/or metastasis and that galectin-3 has a possible role in septic shock. Therefore, galectin inhibitors are of much interest as studies have shown D-galactose, lactose and n-acetyllactosamine to all inhibit galectins with varying binding affinities. Our research is focused on the use of organocobalt and organoiron mediated reactions for the synthesis of potential galectin inhibitors.

 

 

 

 

 

 

 

 

General Posters
8:00 PM-10:00 PM, Tuesday, 12 September 2006 Moscone Center -- Hall D, Poster

Sci-Mix
8:00 PM-10:00 PM, Monday, 11 September 2006 Moscone Center -- Hall D, Sci-Mix

Division of Carbohydrate Chemistry

The 232nd ACS National Meeting, San Francisco, CA, September 10-14, 2006